Birkenallergie

A Multicentre, Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Phase II study to assess the tolerability, safety and efficacy of subcutaneous cluster- immunotherapy in patients suffering from birch pollen allergy

Start: Juni 2020